Id: CBI_1388 | Pages: 225 | Format : PDF | Published : | Author : Amit Sati | Category : Healthcare
Consegic Business Intelligence analyzes that the healthcare and laboratory labels market size is growing with a CAGR of 5.1% during the forecast period (2023-2031), and the market is projected to be valued at USD 14,154.45 Million by 2031 and USD 9,504.69 Million in 2023 from USD 9,106.24 Million in 2022.
Healthcare and laboratory labels are a type of labelling stickers used to mention important information for its appropriate usage. This technique of adding information on labels increases the chances of proper identification and understanding of important information for the user. These labels are generally designed and constructed to tolerate the pressures experienced during storage and distribution over the complete lifecycle of the product.
Moreover, these labels are typically used for labelling purposes in medicines, medical equipment, medical supplies, and other medical products. They provide an excellent solution to communicate the details about products to the user. In addition to this, these labels are extremely useful to prescribe dosage and instruction of the products. Likewise, these labels provide customizable and an attractive addition to the overall product appearance.
Healthcare and laboratory labels are vividly used in healthcare sector to ensure every patient is receiving accurate diagnosis proper medications. These labels are primitively used in labelling of blood and urine samples. Similarly, these labels are also used to provide variety of data such as symptoms, instruction, dosage, procedures, product names, side effects about the product. In addition, based on the analysis, wide utilization of these labels on medical supplies, medical devices, and medical equipment is another predominant factor promoting its high requirement in the market.
Furthermore, rising investments in healthcare sector is certainly directing the market of healthcare and laboratory labels industry to grow in an extensive manner. For instance, according to the statistics published by the Institut Montaigne, a French organization in Jan 2022, the private sector invests an approximate USD 4.36 billion in healthcare sector of France, while the public sector invests around USD 4.91 billion, as it is one of the few sectors to benefit from significant investments in R&D. Therefore, the growing use of healthcare and pharmaceutical labelling in the rising healthcare market is further accelerating the market trend.
Healthcare and laboratory labels have wide range of usage in pharmaceutical sector. These labels are usually utilized to give advantage to consumers by providing the product name, active and inactive ingredients with quantity, dosage, use, instructions, warnings, allergic reactions, among others. Labelling is an important part of pharmaceutical products after packaging. In addition, as per the analysis, the expanding use these labels in prescriptive and over-the-counter medicines is another profound factor driving the market in a particular manner.
Moreover, the increasing trade of pharmaceutical products in the growing economies across the world is also augmenting the requirements for healthcare and laboratory labels, which is further proliferating its market. For instance, according to the data published by the International Trade Administration of U.S. Department of Commerce in July 2022, pharmaceutical products from Bangladesh are exported to almost 150 countries and generated USD 169 million in fiscal year 2020-21, while the Bangladesh pharmaceutical sector is now heading towards self–sufficiency by growing at an annual two-digit growth rate. Therefore, the above-mentioned factors are rigorously boosting the phenomenal market trend.
Limitations associated with healthcare and laboratory labels are limiting their utilization in various sectors. The region-specific labeling slows down the progress of labeled products in the regions with different local language. For instance, according to the data updated by the Nations Online, an organization, in 2023, there are around 7000 spoken languages across the world and about 300 writing systems. Thus, the use of labeling in fixed regional language is further contributing to restrained healthcare and laboratory labels market growth.
Furthermore, the use of paper in the labeling sector is posing a significant environmental concern and further curbing the requirement in the healthcare and laboratory labels market. For instance, according to the data updated by the United Nations in 2023, around 85 billion tons of paper waste are produced each year and 40% of them occupy landfills. Therefore, the aforementioned factors are also creating an obstacle to the appropriate expansion of healthcare and laboratory labels market.
E-labelling is a type of labelling which uses online method of linking information to any kind of barcode. This phenomenal innovation in the labelling sector is expected to expand the product offerings in the rapidly growing healthcare and laboratory labels market. As per the analysis, the extreme potential of this technology to scan barcodes and obtain information about over-the-counter medicines is one of the prominent factors predicted to influence the market in the forthcoming times.
Furthermore, the increasing regulations by the government authorities of several countries will drive the market in an extraordinary manner. For instance, according to the article published by the Regulatory Affairs Professionals Society (RAPS) in September 2023, government of Brazil passed a law requiring medicine package labels to be provided in digital format in addition to the existing written format, as the sponsor must include a QR code on the package of medicines, so that the patient can use the QR code to access the information in the digital format. Thus, contributing to significant trends and healthcare and laboratory labels market opportunities over the forecast period.
Report Attributes | Report Details |
Study Timeline | 2017-2031 |
Market Size in 2031 (USD Billion) | 14,154.45 Million |
CAGR (2023-2031) | 5.1% |
Base Year | 2023 |
By Material | Polyester, Nylon, Polypropylene, Polyolefin, Paper, and Others |
By Type | Product Label, Warning Label, Sample Label, Slide Label, Pharmacy Label, Barcode Label, Identification Label, and Others |
By Application | Medicines, Laboratory Chemicals, Medical Equipment, Medical Supplies, Medical Devices, and Others |
By End-use Industry | Healthcare, Pharmaceutical, Nutraceutical, Blood Banks, Research Centres, and Others |
By Region | North America, Asia-Pacific, Latin America, Europe, Middle East & Africa |
Key Players | CILS, Avery Dennison Corporation, Brady, Schreiner Group, Etisoft.com.pl, Ga International, inotec Barcode Security Ltd., Label Arts, Robinson Tape and Label, Inc., Shamrock Labels, General Data Company, Inc., Watson Label Products, Xinxing Label, cab Produkttechnik GmbH & Co KG, and Leland Company |
The material segment is categorized into polyester, nylon, polypropylene, polyolefin, paper, and others. In 2022, the paper segment accounted for the highest market revenue in the healthcare and laboratory labels market and is also expected to grow at the fastest CAGR over the forecast period. Paper is widely utilized for the preparation of a variety of labels in the healthcare and laboratory labels market. The strong development of this segment is mainly attributed to factors such as the large availability of paper in the market and increased preference for labels prepared from paper owing to the ability to write on paper material. In addition, according to the analysis, disadvantages associated with plastic labeling material is another dominant factor driving the assertive development of the segment in the approaching years.
Moreover, the eco-friendly composition of recycled paper labels is expected to drive the significant demand for these labels in the market. For instance, according to the data updated by the State of California in 2023, eco-choice papers contain a minimum of 50% total recycled fiber with at least 10% content from post-consumer sources. Hence, the aforementioned factors are further inducing the phenomenal development of the segment.
The type segment is categorized into product label, warning label, sample label, slide label, pharmacy label, barcode label, identification label, and others. In 2022, the product label segment accounted for the highest market share of 29.78% in the healthcare and laboratory labels market and is also expected to grow at fastest CAGR over the forecast period. The product label segment has a vast range of applications in medical supplies, medical equipment, medicines, medical devices, among others, owing to its high potential to improve identification of product. As per the analysis, the extraordinary development of the segment is primarily driven by prevalent use of this label in all types of healthcare, laboratory, pharmaceutical, and supplemental products.
Moreover, the impeccable advantages of product label are also expected to drive the significant demand for these labels in the market over the next few years. For instance, according to the data updated by the Commonwealth of Massachusetts in November 2020, a product label is essential to any business as it delivers two functions, which are sales and marketing. The label also provides key information for the consumer such as what is the product, what ingredients it contains, nutrition information, contact information, and more. Hence, the above-mentioned factors are contributing to phenomenal market expansion and trends of the segment in the upcoming years.
The application segment is categorized into medicines, laboratory chemicals, medical equipment, medical supplies, medical devices, and others. In 2022, the medicines segment accounted for the highest market revenue in the healthcare and laboratory labels market and is also expected to grow at fastest CAGR over the forecast period. Medicines have the largest share in the overall healthcare products sector. According to the analysis, the high requirement for directions, dosage, product identification, and allergies in medicines is another incredible factor promoting the phenomenal market development of the segment. In addition to this, the ability of labels to improve organized handling of medicines is also contributing to superior market expansion.
Moreover, the growing production of medicines is one of the profound factors expected to drive market in the upcoming years. For instance, according to the data published by the Association of the British Pharmaceutical Industry (ABPI) in January 2023, manufacturing of medicines in UK has the potential to drive the growth of UK over the next 10 years. Therefore, the above-mentioned factors are also expected to generate strong demand for these labels in the market over the forecast period.
The end-use industry segment is categorized into healthcare, pharmaceutical, nutraceutical, blood banks, research centres, and others. In 2022, the pharmaceutical segment accounted for the highest market share in the this market and is also expected to grow at the fastest CAGR over the forecast period. Pharmaceutical segment utilizes wide range of labeling products for better identification and recognition of pharmaceutical items. Similarly, based on the healthcare and laboratory labels market analysis, strong rise of this segment is also driven by increasing emphasize on mentioning instructions and precautionary measures on pharmaceutical products.
Furthermore, the growth of the segment is also driven by the continuously proliferating market of pharmaceuticals across the globe. For instance, according to the report published by the Business Indonesia in July 2023, pharmaceutical market of Indonesia is the largest market in the Southeast Asia region, with sales of medicines in Indonesia valued at USD 7.6 billion in 2020 and is anticipated to reach USD 176.3 trillion by 2025, with a CAGR of 10.7%. Therefore, the aforementioned factors are expected to support the strong demand for these labels and in turn propel the healthcare and laboratory labels market trends in the next few years.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2022, North America accounted for the highest market share of 38.73% valued at USD 3,526.85 Million in 2022 and USD 3,695.42 Million in 2023 and is expected to reach USD 5,537.22 Million in 2031. In the North American region, the U.S. accounted for the highest healthcare and laboratory labels market share of 65.52% in 2022. The growth of this region is majorly attributed to increased healthcare and laboratory labels market demand in North American countries, owing to dominant presence of manufacturers of healthcare and pharmaceutical products. In addition to this, the phenomenal escalation in the production of pharmaceutical sector is another major sector promoting the development of the market in the region. For instance, according to the report published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) in May 2022, North America accounted for 49.1% of world pharmaceutical sales in 2021, compared to 23.4% in Europe, while U.S. had 64.4% of sales of newly launched medicines during the period 2016-2021, compared to 16.8% in the European market. Thus, contributing to increased requirement for these labels to further propel the market in the region.
However, Asia Pacific is expected to grow at the fastest CAGR of 5.8% during the forecast period. The expansion of this region is majorly attributed to increasing demand for labels in the steadily growing healthcare and pharmaceutical sectors in the region. Similarly, the rising awareness about communicating information about products to their users is another influential factor expected to create opportunities and healthcare and laboratory labels market trends over the forecast period.
The healthcare and laboratory labels market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market trend through mergers, acquisitions, and partnerships. The key players in the market include -
In 2022, the market size of healthcare and laboratory labels was USD 9,106.24 million.
What will be the potential market valuation for the healthcare and laboratory labels market by 2031?
Growing demand for healthcare and laboratory labels in booming healthcare sector is driving the remarkable market growth. Flourishing growth of pharmaceutical industry is contributing to significant market growth.
In 2022, the paper segment accounted for the highest market share in the overall healthcare and laboratory labels market.
Asia Pacific is expected to be the fastest-growing region in the market during the forecast period.